Twist Bioscience (TWST) Enterprise Value (2017 - 2025)
Historic Enterprise Value for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to -$198.0 million.
- Twist Bioscience's Enterprise Value rose 2689.06% to -$198.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$198.0 million, marking a year-over-year increase of 2689.06%. This contributed to the annual value of -$232.4 million for FY2025, which is 1590.64% up from last year.
- According to the latest figures from Q4 2025, Twist Bioscience's Enterprise Value is -$198.0 million, which was up 2689.06% from -$232.4 million recorded in Q3 2025.
- Twist Bioscience's Enterprise Value's 5-year high stood at -$198.0 million during Q4 2025, with a 5-year trough of -$573.9 million in Q1 2022.
- Its 5-year average for Enterprise Value is -$368.0 million, with a median of -$323.8 million in 2023.
- Examining YoY changes over the last 5 years, Twist Bioscience's Enterprise Value showed a top increase of 4860.09% in 2021 and a maximum decrease of 14152.32% in 2021.
- Quarter analysis of 5 years shows Twist Bioscience's Enterprise Value stood at -$301.9 million in 2021, then tumbled by 45.34% to -$438.7 million in 2022, then increased by 29.08% to -$311.1 million in 2023, then rose by 12.96% to -$270.8 million in 2024, then grew by 26.89% to -$198.0 million in 2025.
- Its last three reported values are -$198.0 million in Q4 2025, -$232.4 million for Q3 2025, and -$250.8 million during Q2 2025.